Physical Address

304 North Cardinal St.
Dorchester Center, MA 02124

admin

admin

TDXd Better Than Chemo for HER2-Low Breast Cancer?

BARCELONA, Spain — Trastuzumab deruxtecan (TDXd) shows promise as a treatment for HER2-low and HER2-ultralow hormone receptor (HR)–positive metastatic breast cancer, according to data from the DESTINY-Breast06 trial presented here at the European Society for Medical Oncology (ESMO) Annual Meeting…

en_USEnglish